Cadila Healthcare rose 1.29% to Rs 1,820 at 15:15 IST on BSE after the company said the Zydus group has received the market authorisation from the United States Food & Drug Administration to market Morphine Sulfate ER tablet. The company made announcement ... Business Standard, 2 days ago
Zydus receives market authorisation for Morphine Sulfate ER Tablets - MyIris, 3 days ago
Cadila Health up 3%, Zydus to market pain killer drug in US - Money Control, 3 days ago
3 images for "zydus group"
New Delhi: Pharmaceuticals major Zydus Group on Wednesday announced receipt of approval from the US Food and Drug Administration (FDA) to sell chronic pain reliever morphine sulfate tablets. "The product used in treatment of chronic pain or cancer ...NDTV Profit, 2 days ago Zydus gets USFDA nod to sell morphine sulfate tablets DNA India, 3 days ago Zydus gets USFDA nod for morphine sulfate tablets Money Control, 2 days ago
Mumbai: Cadila Healthcare, the Zydus Cadilla Group flagship, has emerged as the frontrunner to acquire the generic sterile injectables business of Ahmedabad-headquartered Claris Lifesciences Ltd (CLL) trumping several domestic and global peers who ...India Brand Equity Foundation, 1 month ago Cadila Healthcare eyes Claris arm for Rs 3,400 crore Economic Times, 1 month ago Buy Cadila Healthcare; tgt of Rs 1920: Firstcall Research Moneycontrol.com, 1 month ago Cadila Healthcare trumps peers, in talks to acquire Claris Lifesciences for whooping Rs 3,400 crore Business Insider India, 1 month ago
AHMEDABAD: Zydus Cadila registered a net profit of Rs. 1151 crores for the year ended 31st March 2015 — up by 43% from Rs. 804 crores in the previous year. During the year, the company registered gross sales of Rs. 8658 crores, up by 20% from Rs.Times of India, 1 month ago Zydus Cadila Q4 net up 46%; revenues jump 16% Smart Investor, 1 month ago Zydus Cadila Q4 net profit up 46% Livemint.com, 1 month ago Zydus aims to develop drug for fatty liver disease Business Standard India, 1 month ago
Forest cover stopped decreasing in last one year: Javadekar Cyclonic Storm 'Ashobba' over east-central Arabian Sea: IMD Modi statements in B'desh show lack of grace, lowered dignity of PM's office: Cong Dacoits steal 150 sovereigns gold jewels, Rs 2 ...United News of India, 3 weeks ago
K'taka to add 9500 mw through solar energy: Minister Railway Board delegation to visit China, Japan from June 12 Spicejet plans to add 7 aircraft to its fleet Vijai Sharma appointed new Central Information Commissioner Yechury says all three sectors ...United News of India, 3 weeks ago Vijai Sharma appointed new Central Information Commissioner United News of India, 3 weeks ago Railway Board delegation to visit China, Japan from June 12 United News of India, 3 weeks ago K'taka to add 9500 mw through solar energy: Minister United News of India, 3 weeks ago
has earlier worked with agencies such as Grey Worldwide, L&K Saatchi & Saatchi and Access Leo Burnett, Nairobi. DDB Mudra West has roped in Manoj Bhagat as group creative director. Bhagat joins the agency's Mumbai office from Greenapple Design, ...Agencyfaqs!, 1 month ago
Zydus to Present New Scientific Data on Lipaglyn (Saroglitazar), and Real World Data in Patients With Type 2 Diabetes at the American Diabetes Association 75th Scientific Sessions in Boston, USA
/PRNewswire/ -- Zydus Cadila, a leading global healthcare provider, today announced that new scientific and clinical data on Saroglitazar will be presented at the 75th Annual Scientific Sessions of the American Diabetes Association (ADA) in ...Barchart, 3 weeks ago Zydus Cadila to present new clinical data on Lipaglyn at AACE meeting in USA PharmaBiz, 1 month ago
Pieris Pharmaceuticals Appoints Former Celgene and Sanofi Executive, Jean-Pierre Bizzari, M.D., to Its Board of Directors
FREISING, GERMANY Dr. Bizzari was the Executive Vice President, Group Head, Clinical Oncology Development at Celgene Corporation. Since joining Celgene in 2008, he directed the development and approval of a number of leading oncology products ...Digital Journal, 1 month ago Pieris Pharmaceuticals, Inc. (PIRS: OTC Pink Current) | Pieris Pharmaceuticals Prices Public Offering of Common Stock OTC Markets, 3 days ago Pieris Pharmaceuticals Prices Public Offering of Common Stock A.M. Best, 3 days ago PIES PHAR : Pieris Pharmaceuticals Prices Public Offering of Common Stock 4 Traders, 3 days ago
Kelley Drye's Communications Practice Group presents this comprehensive tracker of active Telephone Consumer Protection Act (TCPA) petitions before the Federal Communications Commission (FCC). With the recent increase in litigation regarding alleged ...JD Supra, 1 month ago
on your WebpageAdd Widget >Get your members hooked!